Kayothera Alternatives & Competitors
12 companies similar to Kayothera — Drugging the Undruggable with 1st-in-class RAR/RXR Nuclear Receptor Pathway Inhi...
Companies similar to Kayothera
Genus Oncology LLC
Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
Rival Readout
Competing with Kayothera? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Fore Biotherapeutics
A precision oncology company rooted in science and innovation, developing cancer therapies...
GTx
Innovative and passionate experts providing advanced medicines through proven methods.
Mythic Therapeutics, Inc.
Charting a new dimension in ADC technology
Phoenix Molecular Designs
A clinical stage biopharmaceutical company designing precise cancer therapeutics to addres...
Viracta Therapeutics, Inc.
A precision oncology company focused on the treatment and prevention of virus-associated c...
Ten63 Therapeutics
Explore beyond, leave nothing unseen.
Inoviv
Accelerating the Development of New Medicines with Targeted Proteomics
Madison Vaccines
Developing innovative vaccines for prostate cancer patients and a test to determine their...
About Kayothera
Kayothera, founded in 2019, is a pioneering biotechnology company headquartered in the United States. Their slogan, "Drugging the Undruggable," encapsulates their mission to develop inhibitors for the retinoid and rexinoid nuclear receptors. These pathways are associated with adverse cardiometabolic and cancer outcomes...
Development of small molecule inhibitors, Drug development for cardiometabolic diseases, Innovations in cancer therapy
Patients with type 2 diabetes, Individuals with obesity, Cancer patients, Healthcare providers
Cancer Research, Therapeutics, Pharmaceuticals, Oncology, Drug Development, Medical Innovation, Precision Medicine, Biomedical Engineering
B2B, B2B2C
Licensing, Product Sales, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Kayothera: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Kayothera on 12 Sep 2024. The 12 companies listed here were last checked between 25 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.